# GRWD1

## Overview
The GRWD1 gene encodes the protein glutamate-rich WD repeat-containing 1, which is integral to various cellular processes, including chromatin architecture, DNA replication, and ribosome biogenesis. This protein is characterized by its glutamate-rich acidic domain and WD40 repeat domain, which facilitate protein-protein interactions and contribute to its role in chromatin dynamics and genome integrity (Aizawa2016Nucleosome; Sugimoto2015Cdt1binding). GRWD1 is involved in the regulation of chromatin openness, essential for the loading of the minichromosome maintenance (MCM) complex onto replication origins, a critical step in DNA replication (Sugimoto2015Cdt1binding). Additionally, GRWD1 interacts with ribosomal proteins and is implicated in the ubiquitin-proteasome system, influencing ribosomal protein levels and p53 regulation (Kayama2016GRWD; Watanabe2018GRWD1). Dysregulation of GRWD1 expression is associated with various cancers, where it affects tumor progression and serves as a potential prognostic biomarker and therapeutic target (Ding2022GRWD1; Yao2022GRWD1).

## Structure
GRWD1 is a protein composed of 446 amino acids, featuring a glutamate-rich acidic domain and a WD40 repeat domain. The WD40 repeat domain is homologous to the p48 subunit of CAF1, which is known for its interactions with histones (Aizawa2016Nucleosome; Sugimoto2015Cdt1binding). The WD40 repeats contribute to the formation of a beta-propeller structure, a common fold in proteins that facilitates protein-protein interactions (Watanabe2018GRWD1).

The acidic domain of GRWD1 is crucial for histone binding and is similar to domains found in other histone-binding proteins. This domain plays a significant role in nucleosome disassembly activity, although its deletion does not reduce nucleosome assembly activity, suggesting a specific function in disassembly (Aizawa2016Nucleosome; Sugimoto2015Cdt1binding).

GRWD1 may undergo post-translational modifications such as phosphorylation, which could influence its function and interactions, although specific modifications are not detailed in the provided context (Watanabe2018GRWD1). The presence of splice variant isoforms is suggested, potentially leading to structural and functional diversity, but specific isoforms are not described in the context (Watanabe2018GRWD1).

## Function
The GRWD1 gene encodes a protein that plays a crucial role in chromatin architecture and DNA replication in human cells. GRWD1 is a histone-binding protein that facilitates the loading of the minichromosome maintenance (MCM) complex onto replication origins, a key step in the initiation of DNA replication. This process is dependent on the presence of CDC6 and Cdt1, with GRWD1 binding to replication origins during the G1 phase of the cell cycle (Sugimoto2015Cdt1binding). GRWD1 influences chromatin dynamics by promoting chromatin openness, which is essential for efficient MCM loading and subsequent DNA replication (Sugimoto2015Cdt1binding).

GRWD1 is also involved in maintaining genome integrity by regulating chromatin dynamics and ensuring proper MCM loading, which is crucial for DNA replication and tolerance to replication stress (Sugimoto2015Cdt1binding). The protein is active in the nucleus throughout interphase and is involved in chromatin and nuclear matrix binding (Sugimoto2015Cdt1binding). Additionally, GRWD1 has been implicated in ribosome biogenesis, interacting with ribosomal proteins and transcription-associated factors, and regulating ribosomal protein levels through the ubiquitin-proteasome system (Watanabe2018GRWD1).

## Clinical Significance
Alterations in the expression of the GRWD1 gene have significant clinical implications, particularly in cancer. Overexpression of GRWD1 is associated with poor prognosis in cancer patients, especially those with wild-type p53, as it negatively regulates the p53 tumor suppressor pathway via the RPL11-MDM2 interaction. This suppression of p53 function by GRWD1 is linked to oncogenic transformation, particularly when combined with other oncogenic factors like HPV16 E7 and KRAS G12V (Kayama2016GRWD). 

In gastric cancer, GRWD1 is overexpressed and correlates with increased tumor size, lymph node metastasis, and advanced TNM stage. It promotes cancer cell proliferation, migration, and invasion through the activation of the Notch signaling pathway, suggesting its role as a potential prognostic biomarker and therapeutic target (Ding2022GRWD1). 

In triple-negative breast cancer, GRWD1 is highly expressed and its knockdown results in decreased cell proliferation and increased apoptosis. This is linked to the inactivation of the Notch signaling pathway, indicating GRWD1's role in regulating cancer cell behavior and its potential as a therapeutic target (Yao2022GRWD1). 

Overall, GRWD1's dysregulation is implicated in various cancers, highlighting its significance in tumorigenesis and potential as a target for cancer therapy.

## Interactions
GRWD1, a glutamate-rich WD40 repeat-containing protein, is involved in various protein interactions that play significant roles in cellular processes. It interacts with several ribosomal proteins, including RPL5, RPL11, and RPL23, which are crucial for ribosome biogenesis and function. GRWD1 specifically binds to RPL11, inhibiting its interaction with MDM2, a ubiquitin ligase, thereby affecting p53 regulation. This interaction is stable and does not significantly change under nucleolar stress (Kayama2016GRWD).

GRWD1 also interacts with RPL23, regulating its levels via the ubiquitin-proteasome system. Overexpression of GRWD1 leads to decreased RPL23 levels, suggesting a role in its degradation (Watanabe2018GRWD1). GRWD1's interaction with EDD, an E3 ubiquitin ligase, further supports its involvement in the ubiquitination and degradation of RPL23 (Watanabe2018GRWD1).

In addition to ribosomal proteins, GRWD1 binds to replication origins in a CDC6- and Cdt1-dependent manner, facilitating MCM loading, which is essential for DNA replication. This interaction highlights GRWD1's role in chromatin dynamics and genome integrity (Sugimoto2015Cdt1binding). These interactions underscore GRWD1's multifaceted role in cellular regulation and its potential impact on tumorigenesis.


## References


[1. (Yao2022GRWD1) Liang Yao and Fuguo Tian. Grwd1 affects the proliferation, apoptosis, invasion and migration of triple negative breast cancer through the notch signaling pathway. Experimental and Therapeutic Medicine, May 2022. URL: http://dx.doi.org/10.3892/etm.2022.11400, doi:10.3892/etm.2022.11400. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/etm.2022.11400)

[2. (Sugimoto2015Cdt1binding) Nozomi Sugimoto, Kazumitsu Maehara, Kazumasa Yoshida, Shuhei Yasukouchi, Satoko Osano, Shinya Watanabe, Masahiro Aizawa, Takashi Yugawa, Tohru Kiyono, Hitoshi Kurumizaka, Yasuyuki Ohkawa, and Masatoshi Fujita. Cdt1-binding protein grwd1 is a novel histone-binding protein that facilitates mcm loading through its influence on chromatin architecture. Nucleic Acids Research, 43(12):5898–5911, May 2015. URL: http://dx.doi.org/10.1093/nar/gkv509, doi:10.1093/nar/gkv509. This article has 53 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkv509)

3. (Ding2022GRWD1) GRWD1 overexpression promotes the proliferation, migration, and invasion of gastric cancer through the Notch signaling pathway. This article has 0 citations.

[4. (Watanabe2018GRWD1) Shinya Watanabe, Hiroki Fujiyama, Takuya Takafuji, Kota Kayama, Masaki Matsumoto, Keiichi I. Nakayama, Kazumasa Yoshida, Nozomi Sugimoto, and Masatoshi Fujita. Grwd1 regulates ribosomal protein l23 levels via the ubiquitin-proteasome system. Journal of Cell Science, August 2018. URL: http://dx.doi.org/10.1242/jcs.213009, doi:10.1242/jcs.213009. This article has 15 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.213009)

[5. (Aizawa2016Nucleosome) Masahiro Aizawa, Nozomi Sugimoto, Shinya Watanabe, Kazumasa Yoshida, and Masatoshi Fujita. Nucleosome assembly and disassembly activity of grwd1, a novel cdt1-binding protein that promotes pre-replication complex formation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1863(11):2739–2748, November 2016. URL: http://dx.doi.org/10.1016/j.bbamcr.2016.08.008, doi:10.1016/j.bbamcr.2016.08.008. This article has 12 citations.](https://doi.org/10.1016/j.bbamcr.2016.08.008)

[6. (Kayama2016GRWD) Kota Kayama, Shinya Watanabe, Takuya Takafuji, Takahiro Tsuji, Kensuke Hironaka, Masaki Matsumoto, Keiichi I Nakayama, Masato Enari, Takashi Kohno, Kouya Shiraishi, Tohru Kiyono, Kazumasa Yoshida, Nozomi Sugimoto, and Masatoshi Fujita. <scp>grwd</scp> 1 negatively regulates p53 via the <scp>rpl</scp> 11– <scp>mdm</scp> 2 pathway and promotes tumorigenesis. EMBO reports, 18(1):123–137, November 2016. URL: http://dx.doi.org/10.15252/embr.201642444, doi:10.15252/embr.201642444. This article has 38 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.15252/embr.201642444)